Deutsch English Français

Contact

EP1187834

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP1187834

EP1187834 - POLYMORPHS OF CRYSTALLINE (2-BENZHYDRYL-1-AZABICYCLO 2,2,2 OCT-3-YL)-(5-ISOPROPYL-2-METHOXYBENZYL)-AMMONIUMCHLORIDE AS NK-1 RECEPTOR ANTAGONISTS [Right-click to bookmark this link]
Former [2002/12]	POLYMORPHS OF CRYSTALLINE (2-BENZHYDRYL-1-AZABICYCLO[2,2,2]OCT-3-YL)-(5-ISOPROPYL-2-METHOXYBENZYL)-AMMONIUMCHLORIDE AS NK-1 RECEPTOR ANTAGONISTS
	[2007/45]
Status	The application is deemed to be withdrawn Status updated on 19.05.2006 Database last updated on 18.11.2024
Most recent event Tooltip	05.10.2007	Change - German title	published on 07.11.2007 [2007/45]
Applicant(s)	For all designated states Pfizer Products Inc. Eastern Point Road Groton, CT 06340 / US
	[N/P]
Former [2002/12]	For all designated states Pfizer Products Inc. Eastern Point Road Groton, Connecticut 06340 / US
Inventor(s)	01 / ALLEN, Douglas John, Pfizer Inc. Central Res. Div., Eastern Point Road Groton, CT 06340 / US
	02 / APPLETON, Troy, Anthony, Pfizer Inc. Central Res. Div., Eastern Point Road Groton, CT 06340 / US
	03 / GUMKOWSKI, Michael Jon, Pfizer Inc. Central Res. Div., Eastern Point Road Groton, CT 06340 / US
	04 / MUEHLBAUER, David Joseph, Pfizer Inc. Central Res. Div., Eastern Point Road Groton, CT 06340 / US
	05 / NORRIS, Timothy, Pfizer Inc. Central Res. Div., Eastern Point Road Groton, CT 06340 / US
	[2002/12]
Representative(s)	Rutt, Jason Edward Pfizer ATTENTION: ADDRESS INACTIVE - USE ASS-NR - CDR / FR
	[N/P]
Former [2002/12]	Rutt, Jason Edward Pfizer Limited European Patents Department Ramsgate Road Sandwich, Kent CT13 9NJ / GB
Application number, filing date	00929745.8	06.06.2000
	[2002/12]
	WO2000IB00756
Priority number, date	US19990140233P	22.06.1999 Original published format: US 140233 P
	[2002/12]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO0078759
	Date:	28.12.2000
	Language:	EN
	[2000/52]
	Type:	A1 Application with search report
	No.:	EP1187834
	Date:	20.03.2002
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 28.12.2000 takes the place of the publication of the European patent application.
	[2002/12]
Search report(s)	International search report - published on:	EP	28.12.2000
Classification	IPC:	C07D453/02, A61K31/435, A61P25/28	[2002/12]
	CPC:	C07D453/02 (EP,US); C07D455/02 (KR); A61P1/08 (EP); A61P25/28 (EP); A61P43/00 (EP)
Designated contracting states	AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT [2002/12]
Extension states	AL	21.12.2001
	LT	21.12.2001
	LV	21.12.2001
	MK	21.12.2001
	RO	21.12.2001
	SI	21.12.2001
Title	German:	POLYMORPHE DES KRISTALLINEN (2-BENZHYDRYL-1-AZABICYCLO 2,2,2 OCT-3-YL)-(5-ISOPROPYL-2-METHOXYBENZYL)-AMMONIUMCHLORIDS ALS NK-1-REZEPTORANTAGONISTEN	[2007/45]
	English:	POLYMORPHS OF CRYSTALLINE (2-BENZHYDRYL-1-AZABICYCLO 2,2,2 OCT-3-YL)-(5-ISOPROPYL-2-METHOXYBENZYL)-AMMONIUMCHLORIDE AS NK-1 RECEPTOR ANTAGONISTS	[2007/45]
	French:	POLYMORPHES DU (2-BENZHYDRYL-1-AZABICYCLO 2,2,2 OCT-3-YL)-(5-ISOPROPYL-2-METHOXYBENZYL)-CHLORURE D'AMMONIUM CRISTALLIN UTILISES EN TANT QU'ANTAGONISTES DU RECEPTEUR DE LA NEUROKININE-1	[2007/45]
	Former [2002/12]	POLYMORPHE DES KRISTALLINEN (2-BENZHYDRYL-1-AZABICYCLO[2,2,2]OCT-3-YL)-(5-ISOPROPYL-2-METHOXYBENZYL)-AMMONIUMCHLORIDS ALS NK-1-REZEPTORANTAGONISTEN
	Former [2002/12]	POLYMORPHS OF CRYSTALLINE (2-BENZHYDRYL-1-AZABICYCLO[2,2,2]OCT-3-YL)-(5-ISOPROPYL-2-METHOXYBENZYL)-AMMONIUMCHLORIDE AS NK-1 RECEPTOR ANTAGONISTS
	Former [2002/12]	POLYMORPHES DU (2-BENZHYDRYL-1-AZABICYCLO 2,2,2]OCT-3-YL)-(5-ISOPROPYL-2-METHOXYBENZYL)-CHLORURE D'AMMONIUM CRISTALLIN UTILISES EN TANT QU'ANTAGONISTES DU RECEPTEUR DE LA NEUROKININE-1
Entry into regional phase	21.12.2001	National basic fee paid
	21.12.2001	Designation fee(s) paid
	21.12.2001	Examination fee paid
Examination procedure	20.09.2000	Request for preliminary examination filed International Preliminary Examining Authority: EP
	21.12.2001	Amendment by applicant (claims and/or description)
	21.12.2001	Examination requested [2002/12]
	03.01.2006	Application deemed to be withdrawn, date of legal effect [2006/25]
	07.02.2006	Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time [2006/25]
Fees paid	Renewal fee
	09.08.2002	Renewal fee patent year 03
	11.04.2003	Renewal fee patent year 04
	20.04.2004	Renewal fee patent year 05
	Penalty fee
	Additional fee for renewal fee
	30.06.2002	03 M06 Fee paid on 09.08.2002
	30.06.2005	06 M06 Not yet paid
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited in	International search	[Y]WO9005729 (PFIZER [US]) [Y] 1-21 * claims 1-48 *;
		[Y]WO9221677 (PFIZER [US]) [Y] 1-21 * claims 1-22 *;
		[Y]WO9411368 (PFIZER [US], et al) [Y] 1-21* claims 1-9 *;
		[Y]EP0627221 (PFIZER [US]) [Y] 1-21 * claims 1-14 *

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 34p